Supplementary Table 3. Clinical characteristics between the low AUC and high AUC groups among patients with CVCS.
All (n= 34) | Low AUC (n= 17) | High AUC (n= 17) | p | |
---|---|---|---|---|
Age (year) | 69.4±9.2 | 70.9±10.0 | 67.8±8.4 | 0.342 |
Male (%) | 26 (78.1) | 13 (76.5) | 13 (76.5) | 0.656 |
Smoking (%) | 22 (64.7) | 12 (70.6) | 10 (58.8) | 0.473 |
HT (%) | 34 (100.0) | 17 (100.0) | 17 (100.0) | - |
DM (%) | 16 (47.1) | 7 (41.2) | 9 (52.9) | 0.492 |
DLp (%) | 16 (47.1) | 6 (35.3) | 10 (58.8) | 0.169 |
SBP (mmHg) | 145.2±19.3 | 144.5±16.9 | 145.9±22.0 | 0.828 |
DBP (mmHg) | 68.4±11.1 | 69.7±10.8 | 67.1±11.5 | 0.503 |
ACE-I/ARB (%) | 23 (45.3) | 11 (64.7) | 12 (70.6) | 0.714 |
Statin (%) | 23 (67.6) | 10 (58.8) | 13 (76.5) | 0.271 |
Lanthanum carbonate (%) | 16 (47.1) | 7 (41.2) | 9 (52.9) | 0.492 |
Calcium carbonate (%) | 18 (52.9) | 10 (58.8) | 8 (47.1) | 0.492 |
Sevelamer (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
Bixalomer (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) | - |
Vitamin D (%) | 11 (32.4) | 4 (23.5) | 7 (41.2) | 0.271 |
Warfarin (%) | 3 (8.8) | 2 (11.8) | 1 (5.9) | 0.500 |
Hb (g/dL) | 8.7±1.2 | 8.7±1.3 | 8.9±1.2 | 0.568 |
cCa (mg/dL) | 8.8±0.5 | 8.8±0.7 | 8.7±0.4 | 0.469 |
P (mg/dL) | 5.7±1.3 | 5.3±1.4 | 6.2±0.9 | 0.029 |
Albumin (g/dL) | 3.3±0.4 | 3.2±0.4 | 3.4±0.5 | 0.425 |
Intact PTH (pg/mL) | 235.0 (133.0 – 335.0) | 262.0 (109.0 – 389.0) | 231.0 (157.0 – 330.0) | 0.973 |
CACS | 549.7 (141.8 – 1221.2) | 480.7 (142.5 – 1840.9) | 618.7 (131.8 – 1074.9) | 0.518 |
CVCS | 2.0 (0.0 – 3.0) | 2.0 (0.5 – 4.0) | 2.0(0.0 – 2.5) | 0.231 |
AUC, area under the curve; HT, hypertension; DM, diabetes mellitus; DLp, dyslipidemia; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin II type 1 receptor blocker; Hb, hemoglobin; cCa, corrected calcium; P, phosphate; PTH, parathyroid hormone; CACS, coronary artery calcium score; CVCS, cardiac valvular calcification score.
Values are presented as mean±SD or median (interquartile range).